Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Analysis of neurogranin (NRGN) in schizophrenia.

Smith RL, Knight D, Williams H, Dwyer S, Richards A, Kirov G, O'Donovan MC, Owen MJ.

Am J Med Genet B Neuropsychiatr Genet. 2011 Jul;156B(5):532-5. doi: 10.1002/ajmg.b.31191. Epub 2011 May 2.

PMID:
21538840
2.

The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function.

Rose EJ, Morris DW, Fahey C, Robertson IH, Greene C, O'Doherty J, Newell FN, Garavan H, McGrath J, Bokde A, Tropea D, Gill M, Corvin AP, Donohoe G.

Twin Res Hum Genet. 2012 Jun;15(3):296-303. doi: 10.1017/thg.2012.7.

PMID:
22856365
3.

Functional genetic variation at the NRGN gene and schizophrenia: evidence from a gene-based case-control study and gene expression analysis.

Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Okada T, Kamino K, Morihara T, Iwase M, Kazui H, Numata S, Ikeda M, Ohnuma T, Iwata N, Ueno S, Ozaki N, Ohmori T, Arai H, Takeda M.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jun;159B(4):405-13. doi: 10.1002/ajmg.b.32043. Epub 2012 Mar 27.

PMID:
22461181
4.

Influence of the NRGN gene on intellectual ability in schizophrenia.

Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Fujimoto M, Iwase M, Kazui H, Takeda M.

J Hum Genet. 2013 Oct;58(10):700-5. doi: 10.1038/jhg.2013.82. Epub 2013 Aug 1.

PMID:
23903071
5.

Genetic and functional analysis of the gene encoding neurogranin in schizophrenia.

Shen YC, Tsai HM, Cheng MC, Hsu SH, Chen SF, Chen CH.

Schizophr Res. 2012 May;137(1-3):7-13. doi: 10.1016/j.schres.2012.01.011. Epub 2012 Feb 3.

PMID:
22306195
6.

The impact of genome-wide supported schizophrenia risk variants in the neurogranin gene on brain structure and function.

Walton E, Geisler D, Hass J, Liu J, Turner J, Yendiki A, Smolka MN, Ho BC, Manoach DS, Gollub RL, Roessner V, Calhoun VD, Ehrlich S.

PLoS One. 2013 Oct 2;8(10):e76815. doi: 10.1371/journal.pone.0076815. eCollection 2013.

7.

Association of the gene encoding neurogranin with schizophrenia in males.

Ruano D, Aulchenko YS, Macedo A, Soares MJ, Valente J, Azevedo MH, Hutz MH, Gama CS, Lobato MI, Belmonte-de-Abreu P, Goodman AB, Pato C, Heutink P, Palha JA.

J Psychiatr Res. 2008 Jan;42(2):125-33. Epub 2006 Nov 30.

PMID:
17140601
8.

Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Ohi K, Hashimoto R, Yasuda Y, Nemoto K, Ohnishi T, Fukumoto M, Yamamori H, Umeda-Yano S, Okada T, Iwase M, Kazui H, Takeda M.

PLoS One. 2012;7(1):e29780. doi: 10.1371/journal.pone.0029780. Epub 2012 Jan 12.

9.

Minor allele C of rs12807809 polymorphism in NRGN contributes to the severity of psychosis in patients with Schizophrenia in South Indian population.

Sudesh R, Priyadarshini T, Preeti R, John S, Thara R, Mowry B, Munirajan AK.

Neurosci Lett. 2017 May 10;649:107-111. doi: 10.1016/j.neulet.2017.04.008. Epub 2017 Apr 4.

PMID:
28389239
10.

Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population.

Wen Z, Chen J, Khan RA, Wang M, Song Z, Li Z, Shen J, Li W, Shi Y.

J Affect Disord. 2016 Apr;194:180-7. doi: 10.1016/j.jad.2016.01.034. Epub 2016 Jan 13.

PMID:
26828755
11.

Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China.

Su L, Long J, Pan R, Xie X, Mao X, Zhou Y, Chen Q, Wei B.

Acta Neuropsychiatr. 2015 Aug;27(4):221-7. doi: 10.1017/neu.2015.13. Epub 2015 Mar 5.

PMID:
25739323
12.

A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.

Donohoe G, Walters J, Morris DW, Da Costa A, Rose E, Hargreaves A, Maher K, Hayes E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Moskvina V, Owen MJ, O'Donovan MC, Gill M, Corvin A, Rujescu D.

Schizophr Res. 2011 Feb;125(2-3):304-6. doi: 10.1016/j.schres.2010.10.019. Epub 2010 Nov 26. No abstract available.

PMID:
21112188
13.

The effect of neurogranin on neural correlates of episodic memory encoding and retrieval.

Krug A, Krach S, Jansen A, Nieratschker V, Witt SH, Shah NJ, Nöthen MM, Rietschel M, Kircher T.

Schizophr Bull. 2013 Jan;39(1):141-50. doi: 10.1093/schbul/sbr076. Epub 2011 Jul 28.

14.

CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.

Jones AL, Holliday EG, Mowry BJ, McLean DE, McGrath JJ, Pender MP, Greer JM.

Brain Behav Immun. 2009 Mar;23(3):347-50. doi: 10.1016/j.bbi.2008.09.008. Epub 2008 Sep 26.

PMID:
18848621
15.

Mutation screening and association study of the beta-adrenergic receptor kinase 2 gene in schizophrenia families.

Yu SY, Takahashi S, Arinami T, Ohkubo T, Nemoto Y, Tanabe E, Fukura Y, Matsuura M, Han YH, Zhou RL, Shen YC, Matsushima E, Kojima T.

Psychiatry Res. 2004 Feb 15;125(2):95-104.

PMID:
15006433
16.

Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia.

Thong JY, Qiu A, Sum MY, Kuswanto CN, Tuan TA, Donohoe G, Sitoh YY, Sim K.

PLoS One. 2013 Dec 30;8(12):e85603. doi: 10.1371/journal.pone.0085603. eCollection 2013.

17.

Structure, organization, and chromosomal mapping of the human neurogranin gene (NRGN).

Martínez de Arrieta C, Pérez Jurado L, Bernal J, Coloma A.

Genomics. 1997 Apr 15;41(2):243-9.

PMID:
9143500
18.

Three-cohort targeted gene screening reveals a non-synonymous TRKA polymorphism associated with schizophrenia.

van Schijndel JE, van Loo KM, van Zweeden M, Djurovic S, Andreassen OA, Hansen T, Werge T, Kallunki P, Pedersen JT, Martens GJ.

J Psychiatr Res. 2009 Oct;43(15):1195-9. doi: 10.1016/j.jpsychires.2009.04.006. Epub 2009 May 10.

PMID:
19435634
19.

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Lung FW, Shu BC, Kao WT, Chen CN, Ku YC, Tzeng DS.

BMC Med Genet. 2009 Dec 29;10:147. doi: 10.1186/1471-2350-10-147.

20.

Common variants conferring risk of schizophrenia.

Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Børglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Böttcher Y, Olesen J, Breuer R, Möller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Réthelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA; Genetic Risk and Outcome in Psychosis (GROUP), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA.

Nature. 2009 Aug 6;460(7256):744-7. doi: 10.1038/nature08186. Epub 2009 Jul 1.

Supplemental Content

Support Center